The products offered on this website are furnished for in-vitro studies only. In-vitro studies are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA or EMA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
All articles and product information provided on this website is for informational and educational purposes only.
Urinary tract infections, Peptic ulcers, Anticancer, Heart health, Anti-atherosclerosis, Oral Health
The potential health effects of the consumption of cranberry have been the topic of recent clinical and empirical studies, particularly in the search for further evidence of the phytochemical content of the fruit and associated benefits. It has been found that the bioactive profile of cranberry is different than other berry fruits. They are rich in A-type proanthocyanidins (PACs) whereas other fruits contain B-type PACs.
Its effects on urinary tract infections is particularly relevant as it may reduce the usage of antibiotic treatments to clear the infection which in turn would prevent the development of resistance of antibiotics that may be needed to treat other serious conditions.
To date, studies carried out in human test subjects have been primarily focused on researching its benefits in the treatment of urinary tract problems as well as cardiovascular health. Some studies have also pointed to the fact that the use of cranberries may also be used for treatment of oral and gastrointestinal health.
It has also been found that, since the cranberry constituent avoids the bacteria from adhering to cells, it may also bring benefits in treatments of gastric ulcers and those of the small intestine.
Beyond the studies that have been carried out on humans for the conditions or the urinary tract and gastrointestinal organs, new research is being developed in lab rats to analyse the potential for cancer prevention. During these tests, scientists could observe that infected animals, once exposed to a daily dose of 1ml. of cranberry juice had less bladder tumours than the rats that received only half the dose.
Tumours: Furthermore, other research programs observed that in laboratory tumour models, the use of the cranberry compounds could help inhibit the expansion of cancer affecting the lungs, breast, prostate and colon.
Furthermore, other programs could observe that, in laboratory tumour models, the use of the cranberry compounds could prevent expansion of cancer affecting the lungs, breast, prostate and colon.